43.00
-0.25
(-0.58%)
At close: 12:46:46 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
276,357
110,530.35
154,243.45
182,511.20
262,045.44
Cost of Revenue
242,335.83
101,957.10
88,337.82
105,338.03
174,450.85
Gross Profit
34,021.17
8,573.25
65,905.63
77,173.17
87,594.60
Operating Expense
45,668.76
55,085.03
57,880.30
66,838.75
67,832.67
Operating Income
-11,647.59
-46,511.78
8,025.32
10,334.42
19,761.93
Net Non Operating Interest Income Expense
-4,907.03
-6,019.61
-3,843.30
-3,580.93
-3,080.72
Pretax Income
-19,549.35
-56,558.74
461.23
3,032.70
12,084.40
Tax Provision
1,228.99
1,228.99
1,501.91
1,617.57
4,540.18
Net Income Common Stockholders
-20,778.34
-57,787.73
-1,040.68
1,415.13
7,544.22
Diluted NI Available to Com Stockholders
-20,778.34
-57,787.73
-1,040.68
1,415.13
7,544.22
Basic EPS
-24.84
-34.73
-0.28
0.38
2.00
Diluted EPS
-24.84
-34.73
-0.28
0.38
2.00
Basic Average Shares
1,665.75
1,664.05
3,716.73
3,741.30
3,741.30
Diluted Average Shares
3,741.30
1,664.05
3,716.73
3,741.30
3,741.30
Total Expenses
288,004.59
157,042.13
146,218.13
172,176.78
242,283.51
Net Income from Continuing & Discontinued Operation
-20,778.34
-57,787.73
-1,040.68
1,415.13
7,544.22
Normalized Income
-17,760.40
-54,769.79
1,732.30
4,223.64
10,436.01
Interest Income
--
197.17
156.61
309.08
632.80
Interest Expense
4,115.16
5,227.74
3,817.39
3,549.82
3,607.72
Net Interest Income
-4,907.03
-6,019.61
-3,843.30
-3,580.93
-3,080.72
EBIT
-15,434.19
-51,331
4,278.62
6,582.52
15,692.12
EBITDA
721.27
-34,214.30
23,064.35
25,903.41
35,107.73
Reconciled Cost of Revenue
242,335.83
101,957.10
88,337.82
105,338.03
174,450.85
Reconciled Depreciation
16,155.46
--
18,785.72
19,320.89
19,415.62
Net Income from Continuing Operation Net Minority Interest
-20,778.34
-57,787.73
-1,040.68
1,415.13
7,544.22
Total Unusual Items Excluding Goodwill
-4,311.34
-4,311.34
-3,961.40
-4,012.15
-4,632.10
Total Unusual Items
-4,311.34
-4,311.34
-3,961.40
-4,012.15
-4,632.10
Normalized EBITDA
5,032.60
-29,902.97
27,025.75
29,915.56
39,739.83
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,293.40
-1,293.40
-1,188.42
-1,203.65
-1,740.31
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NOVARTIND.BO Novartis India Limited
817.50
+0.45%
BAJAJHCARE.BO Bajaj HealthCare Limited
622.95
+0.17%
AARTIPHARM.BO Aarti Pharmalabs Limited
717.20
+0.68%
HIKAL.BO Hikal Limited
433.05
+4.50%
ANUHPHR.BO Anuh Pharma Limited
173.70
-0.23%
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,356.95
-1.34%
LUPIN.BO Lupin Limited
1,935.80
-3.79%
GLAND.BO Gland Pharma Limited
1,443.25
+1.17%
STAR.NS Strides Pharma Science Limited
665.10
+7.38%
NEULANDLAB.BO Neuland Laboratories Limited
12,742.10
+0.69%